Search

Your search keyword '"Sparén, P"' showing total 454 results

Search Constraints

Start Over You searched for: Author "Sparén, P" Remove constraint Author: "Sparén, P"
454 results on '"Sparén, P"'

Search Results

201. The economic burden of human papillomavirus-related precancers and cancers in Sweden.

202. Age, period and cohort effects on suicide mortality in Russia, 1956-2005.

203. Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953-2012: a longitudinal cohort study.

204. Registry-based assessment of the status of cervical screening in Sweden.

205. Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.

206. Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban.

207. Sexual and testing behaviour associated with Chlamydia trachomatis infection: a cohort study in an STI clinic in Sweden.

208. Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden.

209. Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.

210. No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.

211. Highest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden.

212. Psychiatric disorder and work life: A longitudinal study of intra-generational social mobility.

213. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.

214. Bereavement Is Associated with an Increased Risk of HPV Infection and Cervical Cancer: An Epidemiological Study in Sweden.

215. Incidence of herpes zoster and associated events including stroke--a population-based cohort study.

216. Occupation and risk of oesophageal adenocarcinoma and squamous-cell carcinoma: The Nordic Occupational Cancer Study.

217. The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.

218. When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance.

219. Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.

220. Cancer incidence among waiters: 45 years of follow-up in five Nordic countries.

221. Occupational exposure to solvents and acute myeloid leukemia: a population-based, case-control study in four Nordic countries.

222. Temporal trends in incidence of myocardial infarction and ischemic stroke by socioeconomic position in Sweden 1987-2010.

223. Common Familial Effects on Ischemic Stroke and Myocardial Infarction: A Prospective Population-Based Cohort Study.

224. Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries.

225. Interventions to improve cervical cancer screening uptake amongst young women: a systematic review.

226. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.

227. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.

228. Cholangiocarcinoma among workers in the printing industry: using the NOCCA database to elucidate the generalisability of a cluster report from Japan.

229. Social class, social mobility and risk of psychiatric disorder--a population-based longitudinal study.

230. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.

231. Occupational exposure to trichloroethylene and perchloroethylene and the risk of lymphoma, liver, and kidney cancer in four Nordic countries.

232. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.

233. Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.

234. Familial risk of premature cardiovascular mortality and the impact of intergenerational occupational class mobility.

235. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.

236. Intergenerational social mobility and the risk of hypertension.

237. Young age at first intercourse and risk-taking behaviours--a study of nearly 65 000 women in four Nordic countries.

238. Familial effects on ischemic stroke: the role of sibling kinship, sex, and age of onset.

239. Screening and cervical cancer cure: population based cohort study.

240. Cervical screening participation and risk among Swedish-born and immigrant women in Sweden.

241. Awareness and knowledge of human papillomavirus in the Swedish adult population.

242. Cancer incidence among priests: 45 years of follow-up in four Nordic countries.

243. Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study.

244. Genital chlamydia, genital herpes, Trichomonas vaginalis and gonorrhea prevalence, and risk factors among nearly 70,000 randomly selected women in 4 Nordic countries.

245. Mortality of eating disorders: a follow-up study of treatment in a specialist unit 1974-2000.

246. Age at diagnosis and disease progression of cystic fibrosis in an area without newborn screening.

247. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden.

248. Assessing perceived risk and STI prevention behavior: a national population-based study with special reference to HPV.

249. Risk of infection-related cancers after the loss of a child: a follow-up study in Sweden.

250. Acceptability of HPV vaccination among young adults aged 18-30 years--a population based survey in Sweden.

Catalog

Books, media, physical & digital resources